Filed: 2/12/2025ACC: 0000950123-25-001612
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $86.75M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$86.75M
Total AUM (reported)
15.74M
Total Shares
Allocation by class
COMMON STOCK$67.12M77.4%
COMMON SHARES$19.62M22.6%
Portfolio Concentration
Top 3$72.31M83.4%
4–10$14.44M16.6%
Top 3 weight
83.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 15.74M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
15.74M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other7
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings7
Rows:
Monte Rosa Therapeutics, Inc.
OTRShares5.65M
TypeSH
Market value$39.23M
45.22%
Sole
0.00
Shared
5.65M
None
0.00
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$19.62M
22.62%
Sole
0.00
Shared
498.56K
None
0.00
Contineum Therapeutics, Inc.
OTRShares918.16K
TypeSH
Market value$13.45M
15.51%
Sole
0.00
Shared
918.16K
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$5.68M
6.55%
Sole
0.00
Shared
2.01M
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$3.47M
4.00%
Sole
0.00
Shared
2.65M
None
0.00
Tempest Therapeutics, Inc.
OTRShares3.51M
TypeSH
Market value$2.93M
3.37%
Sole
0.00
Shared
3.51M
None
0.00
Adverum Biotechnologies, Inc.
OTRShares506.82K
TypeSH
Market value$2.37M
2.73%
Sole
0.00
Shared
506.82K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 5.65M | SH | $39.23M 45.22% | 0.00 | 5.65M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $19.62M 22.62% | 0.00 | 498.56K | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 918.16K | SH | $13.45M 15.51% | 0.00 | 918.16K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $5.68M 6.55% | 0.00 | 2.01M | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $3.47M 4.00% | 0.00 | 2.65M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 3.51M | SH | $2.93M 3.37% | 0.00 | 3.51M | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 506.82K | SH | $2.37M 2.73% | 0.00 | 506.82K | 0.00 |